Disease-modifying therapies can be safely discontinued in an individual with stable relapsing-remitting MS - Commentary.
作者信息
Corboy John R
机构信息
School of Medicine, University of Colorado, Aurora, CO, USA/Rocky Mountain Multiple Sclerosis Center, University of Colorado, Aurora, CO, USA.
出版信息
Mult Scler. 2017 Aug;23(9):1192-1193. doi: 10.1177/1352458517717809. Epub 2017 Jul 4.
PMID:28673113
Abstract
摘要
Zotero 插件